PTC Therapeutics, Inc.
USD68.23
-5.57 (-7.55%)
CEO
Matthew Klein
IPO Date
2013-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$72.76
Prev. Close
$73.80
Day Low
$68.22
Day High
$73.28
52W Low
$43.17
52W High
$87.50
Market Cap
$5.66B
Volume
1.02M
| 2,356 |
| $72.08 |
| 19 May 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | S-Sale | Disposed | 456 | $72.67 |
| 19 May 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | M-Exempt | Disposed | 2,812 | $25.69 |
| 15 May 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 12,500 | $0.00 |
| 15 May 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | S-Sale | Disposed | 679 | $73.06 |
| 15 May 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | S-Sale | Disposed | 7,221 | $73.08 |
| 15 May 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | S-Sale | Disposed | 2,100 | $73.08 |
| 15 May 2026 | Klein Matthew B. | director, officer: CHIEF EXECUTIVE OFFICER | S-Sale | Disposed | 2,572 | $72.46 |
| 12 May 2026 | Boulding Mark Elliott | EXEC. VP AND CLO | M-Exempt | Acquired | 2,740 | $46.54 |